Information Collection

610.15(d) - Constituent Materials

IC 209325 under ICR 201311-0910-007 · OMB 0910-0338.

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0338 can be found here:

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Form 2567 610.15(d) - Constituent Materials	Form and Instruction
2567 Transmittal of Labels and Circulars FORM 2567 11-5-13.pdf	Form and Instruction
356h Application to Market a New Drug Biologic or an Antibiot FORM FDA 356h 11-5-13.zip	Form and Instruction

IC Title:

610.15(d) - Constituent Materials

Agency IC Tracking Number:

Is this a Common Form? No

IC Status: New

Obligation to Respond: Mandatory

CFR Citation: 21 CFR 610.15(d)

Information Collection Instruments:

table that charts list of instruments
Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form and Instruction	2567	Transmittal of Labels and Circulars	FORM 2567 11-5-13.pdf		Yes	Yes	Fillable Printable
Form and Instruction	356h	Application to Market a New Drug Biologic or an Antibiotic Drug for Human Use	FORM FDA 356h 11-5-13.zip		Yes	Yes	Fillable Printable

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records

Title:

FR Citation:

Number of Respondents: 1

Number of Respondents for Small Entity: 0

Affected Public: Private Sector

Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 20 %

table that charts list of burden
	Approved	Change Due to Adjustment in Agency Estimate
Annual Number of Responses for this IC	1	1
Annual IC Time Burden (Hours)	1	1
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.